All posts tagged: masimo

Apple Wins 0 US Jury Verdict in Patent Case Over Masimo Smartwatches

Apple Wins $250 US Jury Verdict in Patent Case Over Masimo Smartwatches

Published by Webster

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo’s smartwatches infringe two of its design patents as part of a broader intellectual property dispute between the companies. The jury, in Delaware, agreed with Apple that previous iterations of Masimo’s W1 and Freedom watches and chargers willfully violated Apple’s patent rights in smartwatch designs. But the jury awarded the tech giant, which is worth about $3.5 trillion, just $250 in damages – the statutory minimum for infringement in the United States. Apple’s attorneys told the court the “ultimate purpose” of its lawsuit was not money, but to win an injunction against sales of Masimo’s smartwatches after an infringement ruling. On that front, jury also determined that Masimo’s current watches did not infringe Apple patents covering inventions that the tech giant had accused Masimo of copying. Masimo said in a statement it appreciated the jury’s verdict “in favor of Masimo and against Apple on nearly all issues,” and that the decision only applied to a “discontinued module and charger.” “Apple …

Apple wins a battle (and 0) in its smartwatch patent fight with Masimo

Apple wins a battle (and $250) in its smartwatch patent fight with Masimo

Published by Webster

Apple got a mixed victory in a patent infringement lawsuit against medical device maker Masimo. On Friday, a federal jury determined that Masimo had infringed on some Apple patents, and as part of the verdict, Apple was awarded $250 — yes, just $250 — as a statutory remedy for Masimo’s infringement. $250 is the statutory minimum damages for the alleged infringement and Apple had sought that figure, Bloomberg Law reports. “We’re not here for the money,” Apple attorney John Desmarais said to jurors in closing arguments, according to the publication. Masimo’s W1 smartwatch, Freedom smartwatch, and health module infringed on one patent, while Masimo’s charger infringed on another, per the verdict form. The jury also found that Masimo’s infringement was willful. Disclaimer: We do not own any of the content, ideas, images, or text presented here. All rights belong to their respective owners. For more information and to view the original source, please visit the following link: Source link

Apple Urges US Appeals Court to Overturn ITC’s Apple Watch Import Ban Amidst Masimo Dispute

Published by Webster

Apple urged a U.S. appeals court on Friday to overturn a U.S. trade tribunal’s decision to ban imports of some Apple Watches in a patent dispute with medical-monitoring technology company Masimo. Apple told the U.S. Court of Appeals for the Federal Circuit that the U.S. International Trade Commission’s decision was based on a “series of substantively defective patent rulings,” and that Masimo failed to show it had invested in making competing U.S. products that would justify the order. Representatives for Apple and Masimo did not immediately respond to requests for comment on the filing. Irvine, California-based Masimo has accused Apple of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Apple first introduced pulse oximetry to its Series 6 Apple Watches in 2020. Masimo convinced the ITC on Dec. 26 to block imports of Apple’s latest-edition Series 9 and Ultra 2 smartwatches after finding that their technology for reading blood-oxygen levels infringed Masimo’s patents. Apple temporarily resumed sales of the watches the next day after persuading the Federal Circuit …

Apple Watch Series 9, Watch Ultra 2 Lose Blood Oxygen Feature to Dodge US Ban

Published by Webster

Apple Watch Series 9 and Apple Watch Ultra 2 will no longer offer the company’s blood oxygen feature on both models in the US, according to the company. In order to dodge a looming US ban on its latest smartwatches, Apple has disabled the pulse oximetry feature on its smartwatches, which infringe on patents held by medical technology firm Masimo. As a result, customers who purchase these two models in the US will not be able to measure their blood oxygen saturation (SpO2) levels. Masimo CEO Joe Kiani told Bloomberg that Apple had not reached out to the medical technology firm to discuss a settlement amid the ongoing legal dispute between both firms. Apple has appealed a ruling of the International Trade Commission (ITC) in October that said the company infringed on Masimo’s patents related to pulse oximetry, a feature that was first introduced with the Apple Watch Series 6. Earlier this week, the Court of Appeals for the Federal Circuit ruled that Apple could not sell both models with the blood oxygen feature, while refusing to pause the …

Apple Removes Blood Oxygen Monitoring Feature From Watches Amid Legal Battle Over Patents

Published by Webster

Masimo accused Apple of infringing on its intellectual property. After a patent dispute with medical device maker Masimo, Apple is removing the pulse oximeter function from its latest smartwatches to avoid a US import ban. The tech giant briefly halted sales of the Apple Watch Series 9 and Ultra 2 last month after a trade commission ruling, but a court allowed temporary sales. To lift the permanent ban, Apple agreed to deactivate the contested feature. Masimo accused Apple of infringing on its intellectual property by using their technology and talent to create the pulse oximeter function. Though a patent lawsuit failed, the International Trade Commission (ITC) sided with Masimo, leading to the import ban. US Customs and Border Protection approved removing the feature to allow Apple to resume sales. According to The New York Times, the International Trade Commission found in October that several Apple Watches had infringed on patents held by Masimo, a medical technology company in Irvine, California, that helped pioneer some pulse oximeter technology. It issued a ban on the import of …

Why Masimo thought it could take on Apple

Published by Webster

For over three years now, Apple has been entrenched in a messy legal battle over a single feature on the Apple Watch — and Apple’s opponent, medical device maker Masimo, seems confident it can win. And there’s a good reason Masimo might believe that: the company came out on top when it sued True Wearables, a startup run by a former executive with a stint on the Apple Watch team, on similar grounds. In 2018, Masimo filed a complaint against True Wearables over claims its wireless pulse oximeter infringed on Masimo’s patent. The court sided with Masimo and issued a permanent injunction against the sale of the device in December 2022. Sound familiar? Well, the pulse oximeter tech isn’t the only parallel between Masimo’s cases against True Wearables and Apple: before starting True Wearables, founder and CEO Marcelo Lamego worked at both Masimo and Apple, where he helped develop similar technologies. Lamego plays a key role in Masimo’s lawsuit, as the company alleges Apple couldn’t have developed some of the technology for the Apple Watch …

Apple Watch Series 9 and Ultra 2 Sale Resumes After Appeals Court Lifts US Ban

Published by Webster

Apple said it would put its latest smartwatch models back on sale in its US retail stores Wednesday after it won a court ruling in a patent fight, providing a quick reprieve for its $17 billion (roughly Rs. 1,41,461 crore) business. The company said its Apple Watch Series 9 and Ultra 2 would also resume online sales beginning Thursday by noon Pacific time. The US International Trade Commission had banned the import and sale of the products at Apple’s official channels after it ruled in favor of Masimo, a medical device maker, in a patent infringement case. An appellate court in Washington had issued an interim stay of the ITC’s decision earlier Wednesday while Apple seeks to overturn the decision. “Apple’s teams have worked tirelessly over many years to develop technology that empowers users with industry-leading health, wellness and safety features and we are pleased the US Court of Appeals for the Federal Circuit has stayed the exclusion order while it considers our request to stay the order pending our full appeal,” a company spokeswoman said …

Apple Files Appeal After Biden Administration Bans Watch Series 9, Watch Ultra 2 Sales in US

Published by Webster

The US has officially banned the import and sale of Apple Watch Series 9 and Watch Ultra 2 models after US President Biden’s administration declined to veto an agency’s decision to restrict the wearables. The move follows an October ruling by the International Trade Commission (ITC) that certain Apple Watch models infringed the blood oxygen saturation technology patented by a medical tech company called Masimo. The affected Apple watches feature a blood oxygen (SpO2) monitoring feature. The Cupertino giant is appealing the federal government ban. An Apple spokesperson said that the company strongly disagrees with the ITC’s order. Apple on Tuesday (December 26) appealed (via Reuters) a decision to ban sales and imports of its latest wearables based on a complaint from Masimo after President Joe Biden’s administration declined to veto USITC earlier today. In a statement, an Apple spokesperson said that it strongly disagrees with the USITC decision and resulting exclusion order, and will be “taking all measures to return the Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the US …

Apple Watch Series 9 and Ultra 2 Online Sales Stopped in the US Ahead of Ban; Older Models Can’t Be Fixed

Published by Webster

Apple has stopped selling the Apple Watch Series 9 and Ultra 2 in the US on its online store, just days before a ban related to a patent dispute takes effect. The company also will no longer be able to repair watch models that are out-of-warranty, a potential headache for consumers. The newest Apple Watch models were no longer available for purchase from the company’s website as of about 3pm Thursday in New York. The company previously said it would end sales at its about 270 physical retail stores in the US on December 24. Online purchasing in the US was stopped earlier than in-store sales so that watches could be sent to consumers before a ban scheduled for December 25 goes into effect. Sales will continue at Apple’s international online and in-person stores. Apple posted a message on the website saying it “no longer sells Apple Watch units in the United States with the ability to measure blood oxygen.” Apple Watch SE models without that feature are still on sale. The sales ban was …

Apple Watch Series 9, Watch Ultra 2 Sales Halted in the US; Company Reportedly Working on Software Fix

Published by Webster

Apple Watch Series 9 and Watch Ultra 2 sales will soon be halted in the US. This comes after an International Trade Commission (ITC) ruling surrounding a patent dispute between Apple and Masimo, a medical technology company that claims that Apple Watch’s blood oxygen sensor technology violates several of their patents. The case is now under a 60-day Presidential Review Period that ends on December 25. There are now also reports of the Cupertino-based tech giant working on a software fix to change how the affected watches measure blood oxygen levels to try and get around a possible sales ban.  In a statement to 9to5Mac, Apple confirmed that the Watch Ultra 2 and Apple Watch Series 9 will not be available to order from the company’s US website after 3pm ET on Thursday, December 21, while in-store inventory from Apple retail locations will be unavailable after December 24. The ITC ruling that prompted this decision only stops Apple from selling the concerned products, which means that they should be available for purchase through other channels like Amazon, Best …